Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.

Journal of translational medicine - 6 Mar 2018

Cai Xiaobo, Li Jun, Yuan Xiaodong, Xiao Jingbo, Dooley Steven, Wan Xinjian, Weng Honglei, Lu Lungen

Abstract excerpt

BACKGROUND: CD133 is a marker of stem cells as well cancer stem cells. This study investigated the association between CD133 expression in cancer cells and the clinical outcome of non-mucin producing intrahepatic cholangiocarcinoma (ICC). METHODS: Fifty-seven non-mucin producing ICC patients were enrolled in this study. Immunohistochemistry (IHC) and immunofluorescence staining for CD133 as well as other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholangiocarcinoma

Share to Disease-Free Survival

Share to Epithelial-Mesenchymal Transition

Share to Mucins

Share to Survival Analysis

Share to Transforming Growth Factor beta1

Source

Open in PubMed Open full text

Identifiers

PMID: 29510695
DOI: 10.1186/s12967-018-1423-9
PMCID: PMC5838940

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.PMID 29510695Read ↗

Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Semantic proximity Read ↗

Recent Advances in Understanding CholangiocarcinomaSemantic proximity Read ↗

Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaSemantic proximity Read ↗

CD44<sup>+</sup>CD133<sup>+</sup>population exhibits cancer stem cell-like characteristics in human gallbladder carcinomaSemantic proximity Read ↗

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinomaSemantic proximity Read ↗

Characterization of CD133+ parenchymal cells in the liver: histology and culture.Semantic proximity Read ↗

Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133Semantic proximity Read ↗

A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-renewal and chemotherapeutic responseSemantic proximity Read ↗

SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistanceSemantic proximity Read ↗

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicitySemantic proximity Read ↗

Interconnection of CD133 Stem Cell Marker with Autophagy and Apoptosis in Colorectal CancerSemantic proximity Read ↗

Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.